bioMérieux – Endotoxin Testing (rFC) – Decoding the future of endotoxin testing
After 50 years of LAL testing, the pharmaceutical industry is transitioning to recombinant Factor C (rFC) methods. USP Chapter…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
IGI and AbbVie announce exclusive global licensing agreement for ISB 2001
IGI Therapeutics, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation (IGI), and AbbVie has announced an…
XTANDI-Leuprolide boosts survival in non-metastatic hormone sensitive high risk Prostate cancer:…
Pfizer and Astellas Pharma has announced positive topline results from the overall survival (OS) analysis from the Phase 3 EMBARK…
Sai Parenterals secures $5.82M equity investment from Marquee investors
Sai Parenterals has announced the successful completion of a USD 5.82 million (Rs 50 crore) equity investment round by a group of…
Lupin signs license and supply agreement with Zentiva for commercialising Certolizumab
Lupin and a pan-European pharmaceutical company, Zentiva have entered into a license and supply agreement for commercialisation of…
Syngene International announces third year of STEM scholarship for women
Syngene International in partnership with the Research and Innovation Circle of Hyderabad (RICH) and Biocon Foundation, announced…
SCHOTT adds knowledge hub to its Pharmaversity
The Knowledge Hub features a collection of more than 100 assets of essential information and expert insights into drug containment…
Clearsynth receives government backing to advance India’s deuterated chemical production
With TDB's support, Clearsynth Labs aims to create a facility that will make India a supplier of high-value deuterated compounds
Pulmonary arterial hypertension market to reach $9.3 bn in 7MM by 2034
GlobalData’s latest report reveals that the US market is the largest PAH market in the 7MM, accounting for 76.3 per cent of global…
Majority of Indian adults seek non-drug weight loss options amid safety concerns over GLP-1…
New survey highlights rising public interest in sustainable, plant-based alternatives to semaglutide and tirzepatide as health…